Jump to navigation
MARKETING dabigatran to general practitioners could lead to the drug being prescribed for patients in whom it has not been proven to be safe or effective, according to an editorial in the Internal Medicine Journal.
If you have an account select Login. If you are new to Medical Observer select Join.
Lynnette Hoffman is an award-winning science and medical journalist and heatlh copywriter.
More articles by this author >
Cirrus Media is Australia’s premier business to business publisher, delivering the country’s most recognised industry magazines and websites.